Register entry
- Registered sites
- 0
- Active NDC listings
- 41
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
4141 active NDC listings: 41 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 41.
| Dosage form | NDCs |
|---|---|
| capsule, liquid filled | 26 |
| capsule, gelatin coated | 14 |
| capsule | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| catalent ontario limited | 41 |
Catalogue
Marketed products
41| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acetaminophen and Phenylephrine Hydrochloride | capsule, gelatin coated | 61474-4148DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide | capsule, liquid filled | 61474-4388DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate | capsule, liquid filled | 61474-4389DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4142DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4397DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4395DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate | capsule, gelatin coated | 61474-4167DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate | capsule, gelatin coated | 61474-4194DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate | capsule, gelatin coated | 61474-4252DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Doxylamine Succinate, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4400DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin | capsule, liquid filled | 61474-4409DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4312DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4317DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4396DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4398DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Phenylephrine Hydrochloride | capsule, liquid filled | 61474-4399DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, and Doxylamine Succinate | capsule | 61474-4254DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide | capsule, gelatin coated | 61474-4195DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide | capsule, gelatin coated | 61474-4203DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Phenylephrine Hydrochloride, and Doxylamine Succinate | capsule, gelatin coated | 61474-4147DRUG FOR FURTHER PROCESSING |
| - | Bisacodyl | capsule, liquid filled | 61474-4390DRUG FOR FURTHER PROCESSING |
| - | Bismuth Subsalicylate | capsule, liquid filled | 61474-4313DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | capsule, liquid filled | 61474-4307DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | capsule, liquid filled | 61474-4370DRUG FOR FURTHER PROCESSING |
| - | DIPHENHYDRAMINE HYDROCHLORIDE | capsule, liquid filled | 61474-4280DRUG FOR FURTHER PROCESSING |
| - | Diclofenac Potassium | capsule, liquid filled | 61474-4181DRUG FOR FURTHER PROCESSING |
| - | Dimenhydrinate | capsule, liquid filled | 61474-4067DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule, gelatin coated | 61474-4033DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule, gelatin coated | 61474-4099DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule, gelatin coated | 61474-4241DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule, gelatin coated | 61474-4281DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | capsule, liquid filled | 61474-4394DRUG FOR FURTHER PROCESSING |
| - | Docusate Sodium | capsule, gelatin coated | 61474-4092DRUG FOR FURTHER PROCESSING |
| - | Doxylamine Succinate | capsule, liquid filled | 61474-4411DRUG FOR FURTHER PROCESSING |
| - | Loratadine | capsule, liquid filled | 61474-4268DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, gelatin coated | 61474-4103DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, liquid filled | 61474-4105DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, gelatin coated | 61474-4172DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, liquid filled | 61474-4302DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, liquid filled | 61474-4311DRUG FOR FURTHER PROCESSING |
| - | Simethicone | capsule, liquid filled | 61474-4342DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing simethicone
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- The Procter & Gamble Manufacturing Company11 sites · 849 NDC
- Haleon US Holdings LLC8 sites · 405 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- P & L Development, LLC5 sites · 119 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- L. Perrigo Company3 sites · 243 NDC
- AmerisourceBergen Drug Corporation2 sites · 47 NDC
- SOFTGEL HEALTHCARE PRIVATE LIMITED2 sites · 38 NDC
Enquiry
Common questions
- Is Catalent Ontario Limited FDA approved?
- Catalent Ontario Limited holds no registered establishment of its own; 41 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Catalent Ontario Limited make?
- 41 products are listed under Catalent Ontario Limited in the openFDA NDC Directory, most often as capsule, liquid filled; capsule, gelatin coated; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.